Duchosal, M.A.
~ 100  results:
Search for persons X
?
1

Clinical usefulness of therapeutic concentration monitoring..:

Gotta, V. ; Widmer, N. ; Decosterd, L. A....
Cancer Chemotherapy and Pharmacology.  74 (2014)  6 - p. 1307-1319 , 2014
 
?
3

Therapeutic Drug Monitoring of the new targeted anticancer ..:

Haouala, A. ; Zanolari, B. ; Rochat, B....
Journal of Chromatography B.  877 (2009)  22 - p. 1982-1996 , 2009
 
?
4

Hereditary Thrombophilia and Venous Thromboembolism: Critic..:

Mazzolai, L. ; Duchosal, M.A.
European Journal of Vascular and Endovascular Surgery.  34 (2007)  4 - p. 483-488 , 2007
 
?
5

Population pharmacokinetics of imatinib and the role of α1‐..:

Widmer, N. ; Decosterd, L. A. ; Csajka, C....
British Journal of Clinical Pharmacology.  62 (2006)  1 - p. 97-112 , 2006
 
?
7

Determination of imatinib (Gleevec®) in human plasma by sol..:

Widmer, N ; Béguin, A ; Rochat, B...
Journal of Chromatography B.  803 (2004)  2 - p. 285-292 , 2004
 
?
9

Swiss Survey on current practices and opinions on clinical ..:

Rovó, A ; Gavillet, M ; Drexler, B...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmed.2023.1200431.  , 2023
 
?
10

Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abr..:

Matsumoto, S ; Biniecka, P ; Bellotti, A..
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15030787.  , 2023
 
?
11

Synthesis and structure-activity relationship of new nicoti..:

Fratta, S ; Biniecka, P ; Moreno-Vargas, A.J...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejmech.2023.115170.  , 2023
 
?
12

Anticancer Activities of Novel Nicotinamide Phosphoribosylt..:

Biniecka, P ; Matsumoto, S ; Belotti, A...
info:eu-repo/semantics/altIdentifier/doi/10.3390/molecules28041897.  , 2023
 
?
13

Humoral Responses Against Variants of Concern by COVID-19 m..:

Obeid, M ; Suffiotti, M ; Pellaton, C...
info:eu-repo/semantics/altIdentifier/doi/10.1001/jamaoncol.2022.0446.  , 2022
 
?
14

Identification of NAPRT Inhibitors with Anti-Cancer Propert..:

Ghanem, M.S ; Caffa, I ; Del Rio, A...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ph15070848.  , 2022
 
?
15

Gut microbiota severely hampers the efficacy of NAD-lowerin..:

ElMokh, O ; Matsumoto, S ; Biniecka, P...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41419-022-04763-3.  , 2022
 
1-15